300 related articles for article (PubMed ID: 34409886)
1. Gabapentinoid Dosing and Associated Toxicities in Patients With or Without Concomitant Opioids During Hospitalization.
Tu TG; Sadeghi S; Atayee R; Lee K
Am J Hosp Palliat Care; 2022 May; 39(5):530-534. PubMed ID: 34409886
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Analysis of Gabapentinoid and Opioids to Opioid Monotherapy for Pain Relief in Patients with Chronic Neck and Low Back Pain.
Knezevic NN; Aijaz T; Camacho-Ortega A; Candido KD
Pain Med; 2021 Aug; 22(8):1760-1766. PubMed ID: 33502505
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
Waddy SP; Becerra AZ; Ward JB; Chan KE; Fwu CW; Eggers PW; Abbott KC; Kimmel PL
Am J Nephrol; 2020; 51(6):424-432. PubMed ID: 32428902
[TBL] [Abstract][Full Text] [Related]
5. Risk of respiratory depression with opioids and concomitant gabapentinoids.
Savelloni J; Gunter H; Lee KC; Hsu C; Yi C; Edmonds KP; Furnish T; Atayee RS
J Pain Res; 2017; 10():2635-2641. PubMed ID: 29180889
[TBL] [Abstract][Full Text] [Related]
6. Dose-Dependent Association of Gabapentinoids with Pulmonary Complications After Total Hip and Knee Arthroplasties.
Ohnuma T; Raghunathan K; Moore S; Setoguchi S; Ellis AR; Fuller M; Whittle J; Pyati S; Bryan WE; Pepin MJ; Bartz RR; Haines KL; Krishnamoorthy V
J Bone Joint Surg Am; 2020 Feb; 102(3):221-229. PubMed ID: 31804238
[TBL] [Abstract][Full Text] [Related]
7. Fatalities associated with gabapentinoids in England (2004-2020).
Kalk NJ; Chiu CT; Sadoughi R; Baho H; Williams BD; Taylor D; Copeland CS
Br J Clin Pharmacol; 2022 Aug; 88(8):3911-3917. PubMed ID: 35435281
[TBL] [Abstract][Full Text] [Related]
8. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland.
Torrance N; Veluchamy A; Zhou Y; Fletcher EH; Moir E; Hebert HL; Donnan PT; Watson J; Colvin LA; Smith BH
Br J Anaesth; 2020 Aug; 125(2):159-167. PubMed ID: 32571568
[TBL] [Abstract][Full Text] [Related]
9. Trends in Gabapentin and Pregabalin Prescribing in a Tertiary Pediatric Medical Center.
Donado C; Nedeljkovic K; Wangnamthip S; Solodiuk JC; Bourgeois FT; Berde CB
Hosp Pediatr; 2021 Aug; 11(8):909-914. PubMed ID: 34257145
[TBL] [Abstract][Full Text] [Related]
10. Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
Muanda FT; Weir MA; Ahmadi F; Sontrop JM; Cowan A; Fleet JL; Blake PG; Garg AX
Am J Kidney Dis; 2022 Jul; 80(1):98-107.e1. PubMed ID: 34979160
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.
Knowles GM; LaFleur GE; Churchwell MD
J Pharm Technol; 2024 Feb; 40(1):30-36. PubMed ID: 38318261
[No Abstract] [Full Text] [Related]
12. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States.
Bykov K; Bateman BT; Franklin JM; Vine SM; Patorno E
JAMA Netw Open; 2020 Dec; 3(12):e2031647. PubMed ID: 33372975
[TBL] [Abstract][Full Text] [Related]
13. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
[No Abstract] [Full Text] [Related]
14. [Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?].
Echeverría Gorriti A; Alzueta Istúriz N; García González P; Fernández González J; Sanz Álvarez L; Garjón Parra J
Gac Sanit; 2023; 37():102283. PubMed ID: 36565565
[TBL] [Abstract][Full Text] [Related]
15. Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries.
Zhou L; Bhattacharjee S; Kwoh CK; Malone DC; Tighe PJ; Reisfield GM; Slack M; Wilson DL; Lo-Ciganic WH
Value Health; 2021 Feb; 24(2):196-205. PubMed ID: 33518026
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
Goodman CW; Brett AS
JAMA Intern Med; 2019 May; 179(5):695-701. PubMed ID: 30907944
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin and gabapentin in non-opioid poisoning deaths.
Kriikku P; Ojanperä I
Forensic Sci Int; 2021 Jul; 324():110830. PubMed ID: 34000615
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
Liu B; Liu R; Wang L
Medicine (Baltimore); 2017 Sep; 96(37):e8031. PubMed ID: 28906391
[TBL] [Abstract][Full Text] [Related]
19. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
[TBL] [Abstract][Full Text] [Related]
20. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
Evoy KE; Covvey JR; Peckham AM; Reveles KR
Int J Clin Pharm; 2021 Aug; 43(4):1055-1064. PubMed ID: 33387188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
